| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9c105a60d79829ff725dee4fa418880 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2543-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2010-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5652973e926ab74de4d8ab9fcd9878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a31d712713680d178df00e2d3a2c84 |
| publicationDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3045546-A1 |
| titleOfInvention |
Methods of classifying biological samples for predicting response to tyrosine kinase inhibitor treatment |
| abstract |
Gene copy numbers of signaling components downstream of EGFR identify non- small cell lung cancer (NSCLC) patients with poor outcomes on 2nd/3rd line gefitinib therapy. |
| priorityDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |